Suppr超能文献

[骨质疏松症治疗与甲状腺功能。6个月氟化钠治疗对甲状腺功能和骨密度的影响]

[Osteoporosis therapy and thyroid function. Influence of 6 months of sodium fluoride treatment on thyroid function and bone density].

作者信息

Eichner R, Börner W, Henschler D, Köhler W, Moll E

出版信息

Fortschr Med. 1981 Mar 12;99(10):342-8.

PMID:7216100
Abstract

26 women were treated for osteoporosis with 40 mg of sodium fluoride twice a day (equivalent 36 mg of fluorine) for a longer period. Mostly by reason of incompatibility, a reduction to half of the dose was necessary in six of these patients. The control of plasma fluoride concentration indicated that only 10 patients took their medicine regularly. Before treatment as well as three and six months after beginning of treatment the patients were examined. In these examinations bone density was measured across the middle phalanx of the middle finger with a I-125-profile scanner. Size and function of the thyroid gland were evaluated by clinical aspects and with in vivo- and in vitro-methods for thyroid diagnostic. The program includes also a check up with a 12 canal-serum-autoanalyzer. In 10 patients with warranted regular intake of the drug the increase of bone density was significant after three months already. In all 26 patients a considerable increase of the alkaline phosphatase after three months was evident. Under the influence of sodium fluoride no change was seen in function and size of thyroid gland. This result verifies the efficiency of sodium fluoride in osteoporosis-therapy without any measurable influence on thyroid function.

摘要

26名患有骨质疏松症的女性接受了为期较长时间的治疗,每天两次服用40毫克氟化钠(相当于36毫克氟)。主要由于药物不相容性,其中6名患者需要将剂量减半。血浆氟浓度的监测表明,只有10名患者按时服药。在治疗前以及治疗开始后的三个月和六个月对患者进行了检查。在这些检查中,使用I - 125轮廓扫描仪测量中指中节指骨的骨密度。通过临床检查以及甲状腺诊断的体内和体外方法评估甲状腺的大小和功能。该项目还包括使用12通道血清自动分析仪进行检查。在10名有规律服药保证的患者中,三个月后骨密度就有了显著增加。在所有26名患者中,三个月后碱性磷酸酶明显大幅增加。在氟化钠的影响下甲状腺的功能和大小未见变化。这一结果证实了氟化钠在骨质疏松症治疗中的有效性,且对甲状腺功能没有任何可测量的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验